- Home
- STXS
STXS
Stereotaxis Inc.
as 04-03-2025 4:00pm EST
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | ST.LOUIS |
| Market Cap: | N/A | IPO Year: | 2004 |
| Target Price: | N/A | AVG Volume (30 days): | 590.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.64 - $3.29 | Next Earning Date: | 05-12-2025 |
| Revenue: | $26,918,000 | Revenue Growth: | 0.55% |
| Revenue Growth (this year): | 34.9% | Revenue Growth (next year): | 58.64% |
Stock Insider Trading Activity of Stereotaxis Inc. (STXS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Isaac Paul J | STXS | Director | Mar 6 '25 | Buy | $1.80 | 24,788 | $44,836.50 | 49,066 |
Latest Stereotaxis Inc. News
STXS Breaking Stock News: Dive into STXS Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025
Insider Monkey
11 days ago
Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic Surgery
Zacks
13 days ago
Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now?
Simply Wall St.
14 days ago
March 2025 Penny Stocks With Promising Prospects
GlobeNewswire
16 days ago
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
GlobeNewswire
25 days ago
Stereotaxis to Present at 37th Annual Roth Conference
Zacks
a month ago
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission
Zacks
a month ago
STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval
Compare STXS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STXS Stereotaxis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.